bioAffinity Technologies (BIAFW) Competitors

$0.32
0.00 (0.00%)
(As of 05/17/2024 ET)

BIAFW vs. PRENW, SQLLW, STRRP, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, and ALVO

Should you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Prenetics Global (PRENW), SeqLL (SQLLW), Star Equity (STRRP), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), and Alvotech (ALVO). These companies are all part of the "medical" sector.

bioAffinity Technologies vs.

Prenetics Global (NASDAQ:PRENW) and bioAffinity Technologies (NASDAQ:BIAFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation.

Prenetics Global and bioAffinity Technologies both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Prenetics GlobalN/AN/A
bioAffinity TechnologiesN/AN/A

In the previous week, bioAffinity Technologies' average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
bioAffinity Technologies Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
bioAffinity Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$21.74MN/AN/AN/AN/A
bioAffinity Technologies$2.53MN/AN/AN/AN/A

Summary

Prenetics Global beats bioAffinity Technologies on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIAFW vs. The Competition

MetricbioAffinity TechnologiesDiagnostics & Research IndustryMedical SectorNASDAQ Exchange
Market CapN/A$11.61B$5.30B$7.96B
Dividend YieldN/A4.81%43.94%3.91%
P/E RatioN/A556.85154.7018.77
Price / SalesN/A1,154.322,362.9377.92
Price / CashN/A11.6336.6031.98
Price / BookN/A3.145.754.76
Net IncomeN/A$365.55M$106.86M$217.17M
7 Day Performance-17.95%-0.48%1.41%2.90%
1 Month Performance-34.68%5.78%4.29%6.57%
1 Year Performance-10.51%-16.21%7.61%10.17%

bioAffinity Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRENW
Prenetics Global
0 of 5 stars
$0.01
flat
N/AN/A$0.00$21.74M0.00400Gap Up
SQLLW
SeqLL
0 of 5 stars
$0.00
flat
N/AN/A$0.00$1,177.000.007
STRRP
Star Equity
0 of 5 stars
$9.26
+0.7%
N/A-0.6%$0.00$45.79M0.00171News Coverage
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-58.0%$0.00N/A0.004News Coverage
Positive News
Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.08
-28.6%
N/AN/A$0.00$253,573.000.002Positive News
Gap Down
ACONW
Aclarion
0 of 5 stars
$0.03
-25.5%
N/AN/A$0.00$75,404.000.004Gap Up
AIMDW
Ainos
0 of 5 stars
$0.04
-33.0%
N/A-81.8%$0.00$122,112.000.0046Positive News
Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.23
flat
N/A-28.1%$0.00N/A0.00121Short Interest ↓
Positive News
Gap Down
ALVOW
Alvotech
0 of 5 stars
$2.89
-11.1%
N/A+158.3%$0.00$91.43M0.00999Positive News
Gap Down
ALVO
Alvotech
0.018 of 5 stars
$13.35
+0.5%
$12.67
-5.1%
+55.2%$0.00$93.38M-5.491,026Upcoming Earnings

Related Companies and Tools

This page (NASDAQ:BIAFW) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners